Brief: Mei Pharma Responds To Anson And Cable Car
18/07/2023 14:14
July 18 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA RESPONDS TO ANSON AND CABLE CAR
* MEI PHARMA INC - RESPONDS TO ANSON AND CABLE CAR
* MEI PHARMA INC - BOARD HAS NOT MADE OR PROPOSED ANY
MODIFICATION
OF BYLAWS TO DATE, NOR DOES IT HAVE ANY CURRENT INTENTION TO DO
SO
* MEI PHARMA INC - REITERATES ITS RECOMMENDATION THAT
SHAREHOLDERS
VOTE FOR PENDING TRANSACTION WITH INFINITY PHARMACEUTICS
* MEI PHARMA INC - ANSON AND CABLE CAR ATTEMPT TO REMOVE
OUR
BOARD OF DIRECTORS WITHOUT CAUSE IS "NOT ALLOWED" UNDER DELAWARE
LAW
Source text for Eikon: ID:nBw1ffd0Da
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations